Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AuraGen 123 Suction Lipoplasty System (A123)

K-Number: K190278 · 2019-05-03

Decision Date2019-05-03
Product CodeMUU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

AuraGen 123 Suction Lipoplasty System (A123) is a medical device manufactured by Auragen Aesthetics, LLC. It received FDA 510(k) clearance on 2019-05-03 under approval number K190278. The device is classified under product code MUU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AuraGen 123 Suction Lipoplasty System (A123)?

AuraGen 123 Suction Lipoplasty System (A123) is a medical device that received FDA 510(k) clearance on 2019-05-03. It is manufactured by Auragen Aesthetics, LLC. The 510(k) number is K190278.

When was AuraGen 123 Suction Lipoplasty System (A123) approved by the FDA?

AuraGen 123 Suction Lipoplasty System (A123) received FDA 510(k) clearance on 2019-05-03, under approval number K190278.

What company makes AuraGen 123 Suction Lipoplasty System (A123)?

AuraGen 123 Suction Lipoplasty System (A123) is manufactured by Auragen Aesthetics, LLC.

What is the FDA product code for AuraGen 123 Suction Lipoplasty System (A123)?

The FDA product code for AuraGen 123 Suction Lipoplasty System (A123) is MUU.

Related Clinical Trials

Related Devices (Code: MUU)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.